"20% to 30% of patients develop a persistent, hard-to-treat illness."
Ulrike Schmidt, PhD, MRCPsych
Advertisement
Articles by Ulrike Schmidt, PhD, MRCPsych
Advertisement
Latest Updated Articles
The Status of Neuromodulation Trials in Eating DisordersPublished: February 17th 2023 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
Lithium-Loaded Gold Nanoparticle Nasal Spray to Treat Neuropsychiatric Diseases
2
Preliminary Report on Dangers of AI Chatbots
3
The Trial of ChatGPT: What Psychiatrists Need to Know About AI, Suicide, and the Law
4
Suicide: Can Emergency Departments Assist in its Prevention?
5
